Skip to main content

and
  1. Article

    Open Access

    Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia

    Acute myeloid leukemia (AML) is a myeloid neoplasm makes up 7.6% of hematopoietic malignancies. Super-enhancers (SEs) represent a special group of enhancers, which have been reported in multiple cell types. In...

    Fang Fang, Jun Lu, Xu Sang, Yan-Fang Tao in Journal of Experimental & Clinical Cancer … (2022)

  2. Article

    Open Access

    BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma

    Neuroblastoma (NB) is a common extracranial malignancy with high mortality in children. Recently, super-enhancers (SEs) have been reported to play a critical role in the tumorigenesis and development of NB via...

    Yan-Ling Chen, **ao-Lu Li, Gen Li, Yan-Fang Tao, Ran Zhuo, Hai-Bo Cao in Cell & Bioscience (2022)

  3. Article

    Open Access

    SAPCD2 promotes neuroblastoma progression by altering the subcellular distribution of E2F7

    Recent studies uncovered the emerging roles of SAPCD2 (suppressor anaphase-promoting complex domain containing 2) in several types of human cancer. However, the functions and underlying mechanisms of SAPCD2 in...

    Zi-Mu Zhang, Hai-Bo Cao, Zhi-Heng Li, Ran Zhuo, Yan-Fang Tao in Cell Death & Disease (2022)

  4. Article

    Open Access

    CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1

    Acute myeloid leukemia (AML) is a myeloid neoplasm accounts for 7.6% of hematopoietic malignancies. AML is a complex disease, and understanding its pathophysiology is contributing to the improvement in the tre...

    You Jiang, Shui-Yan Wu, Yan-Ling Chen, Zi-Mu Zhang in Cancer Cell International (2021)

  5. Article

    Open Access

    Molecular mechanism of G1 arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells

    Overexpression of cyclin D1 dependent kinases 4 and 6 (CDK4/6) is a common feature of many human cancers including leukemia. LEE011 is a novel inhibitor of both CDK4 and 6. To date, the molecular function of L...

    Yan-Fang Tao, Na-Na Wang, Li-**ao Xu, Zhi-Heng Li, **ao-Lu Li in Cancer Cell International (2017)

  6. Article

    Open Access

    Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia

    Acute myeloid leukemia (AML) is the second-most common form of leukemia in children. Aberrant DNA methylation patterns are a characteristic feature of AML. GATA4 has been suggested to be a tumor suppressor gen...

    Yan-Fang Tao, Fang Fang, Shao-Yan Hu, Jun Lu, Lan Cao, Wen-Li Zhao in BMC Cancer (2015)

  7. Article

    Open Access

    Analyzing the gene expression profile of anaplastic histology Wilms’ tumor with real-time polymerase chain reaction arrays

    Wilms’ tumor (WT) is one of the most common malignant neoplasms of the urinary tract in children. Anaplastic histology (unfavorable histology) accounts for about 10% of whole WTs, and it is the single most imp...

    Jun Lu, Yan-Fang Tao, Zhi-Heng Li, Lan Cao, Shao-Yan Hu in Cancer Cell International (2015)

  8. Article

    Open Access

    Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia

    Pediatric acute myeloid leukemia (AML) comprises up to 20% of all childhood leukemia. Recent research shows that aberrant DNA methylation patterning may play a role in leukemogenesis. The epigenetic silencing ...

    Yan-Fang Tao, Li-**ao Xu, Jun Lu in Journal of Experimental & Clinical Cancer … (2015)

  9. Article

    Open Access

    Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway

    Histone acetyltransferase (HAT) inhibitors can inhibit proliferation and induce apoptosis in cancer cell lines. The novel cell-permeable p300/CREB-binding protein (CBP)-selective HAT inhibitor HATi II can redu...

    Li-**ao Xu, Zhi-Heng Li, Yan-Fang Tao in Journal of Experimental & Clinical Cancer … (2014)

  10. Article

    Open Access

    Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation

    Acute myeloid leukemia (AML) is the second most common form of leukemia in children. Aberrant DNA methylation patterns are a characteristic feature in various tumors, including AML. Metallothionein III (MT3) i...

    Yan-Fang Tao, Li-**ao Xu, Jun Lu, Lan Cao, Zhi-Heng Li in Journal of Translational Medicine (2014)

  11. Article

    Open Access

    Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells

    Survivin, a member of the family of inhibitor of apoptosis proteins, functions as a key regulator of mitosis and programmed cell death. YM155, a novel molecular targeted agent, suppresses survivin, which is ov...

    Yan-Fang Tao, Jun Lu, **ao-Juan Du, Li-Chao Sun, Xuan Zhao, Liang Peng in BMC Cancer (2012)

  12. Article

    Open Access

    ATP synthase ecto-α-subunit: a novel therapeutic target for breast cancer

    Treatment failure for breast cancer is frequently due to lymph node metastasis and invasion to neighboring organs. The aim of the present study was to investigate invasion- and metastasis-related genes in brea...

    Jian Pan, Li-Chao Sun, Yan-Fang Tao, Zhuan Zhou in Journal of Translational Medicine (2011)

  13. Article

    Open Access

    An novel role of sphingosine kinase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma

    Treatment failure for esophageal carcinoma is frequently due to lymph node metastasis and invasion to neighboring organs. The aim of the present study was to investigate invasion- and metastasis-related genes ...

    Jian Pan, Yan-Fang Tao, Zhuan Zhou, Bang-rong Cao in Journal of Translational Medicine (2011)